Organogenesis Holdings Stock Analysis

Organogenesis Stock Analysis Notes

About 47.0% of the company outstanding shares are owned by corporate insiders. The book value of Organogenesis Holdings was now reported as 2.09. The company recorded a loss per share of 0.01. Organogenesis Holdings had not issued any dividends in recent years. Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company was founded in 1985 and is headquartered in Canton, Massachusetts. Organogenesis Holdings operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 950 people. To find out more about Organogenesis Holdings contact Gary Sr at 781 575 0775 or learn more at https://organogenesis.com.

Organogenesis Holdings Investment Alerts

Organogenesis Holdings Upcoming and Recent Events

Organogenesis Largest EPS Surprises

View All Earnings Estimates

Organogenesis Holdings Environmental, Social, and Governance (ESG) Scores

Organogenesis Stock Institutional Investors

Note, although Organogenesis Holdings' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Organogenesis Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 662.04 M.

Organogenesis Profitablity

Management Efficiency

Organogenesis Holdings has return on total asset (ROA) of 0.0281 % which means that it generated a profit of $0.0281 on every $100 spent on assets. This is way below average. Organogenesis Holdings' management efficiency ratios could be used to measure how well Organogenesis Holdings manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Organogenesis Holdings' Return On Tangible Assets are very stable compared to the past year. As of the 26th of March 2025, Return On Assets is likely to grow to 0, while Return On Capital Employed is likely to drop (0). At this time, Organogenesis Holdings' Return On Assets are very stable compared to the past year. As of the 26th of March 2025, Asset Turnover is likely to grow to 1.18, while Total Assets are likely to drop about 315.7 M.

Technical Drivers

As of the 26th of March, Organogenesis Holdings holds the Coefficient Of Variation of 1153.93, semi deviation of 3.88, and Risk Adjusted Performance of 0.0825. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organogenesis Holdings, as well as the relationship between them.

Organogenesis Holdings Price Movement Analysis

Organogenesis Holdings Insider Trading Activities

Organogenesis Holdings Outstanding Bonds

Organogenesis Holdings Predictive Daily Indicators

Organogenesis Holdings Corporate Filings

Organogenesis Holdings Forecast Models

Organogenesis Holdings' time-series forecasting models are one of many Organogenesis Holdings' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organogenesis Holdings' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Organogenesis Holdings prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organogenesis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Organogenesis Holdings. By using and applying Organogenesis Stock analysis, traders can create a robust methodology for identifying Organogenesis entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Organogenesis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Organogenesis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Organogenesis Holdings stock analysis indicators help investors evaluate how Organogenesis Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Organogenesis Holdings shares will generate the highest return on investment. By understating and applying Organogenesis Holdings stock analysis, traders can identify Organogenesis Holdings position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.